[go: up one dir, main page]

NO972868L - Oligonukleotid-dendrimer konjugater - Google Patents

Oligonukleotid-dendrimer konjugater

Info

Publication number
NO972868L
NO972868L NO972868A NO972868A NO972868L NO 972868 L NO972868 L NO 972868L NO 972868 A NO972868 A NO 972868A NO 972868 A NO972868 A NO 972868A NO 972868 L NO972868 L NO 972868L
Authority
NO
Norway
Prior art keywords
dendrimer
oligonucleotide
natural
modified
nucleic acid
Prior art date
Application number
NO972868A
Other languages
English (en)
Other versions
NO972868D0 (no
Inventor
Robert Haener
Konstantinos Skobridis
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO972868D0 publication Critical patent/NO972868D0/no
Publication of NO972868L publication Critical patent/NO972868L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Oligonukleotid-dendrimer konjugater, der dendrimeren er et enverdig residie av en dendrimer av første til tiende generasjon og oligonukleotidet er en naturlig, modifisert eller syntetisk sekvens som består av naturlige, modifiserte eller syntetiske deoksynukleosider eller peptidnukleinsyrebyggeblokker som er bundet via intemukleotidbroer og som omfatter en region som er komplementær, fortrinnsvis fullstendig komplementær, til en målnukleinsyre (mål-RNA eller mål-DNA), der dendrimeren er bundet til en intemukleotidbro, en nukleinsyrebase eller en sukker av nukleotidet, og saltene av disse.
NO972868A 1994-12-21 1997-06-20 Oligonukleotid-dendrimer konjugater NO972868L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH385494 1994-12-21
CH4795 1995-01-09
PCT/EP1995/004933 WO1996019240A1 (en) 1994-12-21 1995-12-13 Oligonucleotide-dendrimer conjugates

Publications (2)

Publication Number Publication Date
NO972868D0 NO972868D0 (no) 1997-06-20
NO972868L true NO972868L (no) 1997-08-19

Family

ID=25683356

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972868A NO972868L (no) 1994-12-21 1997-06-20 Oligonukleotid-dendrimer konjugater

Country Status (8)

Country Link
EP (1) EP0790837A1 (no)
JP (1) JPH10510822A (no)
AU (1) AU4344696A (no)
CA (1) CA2206915A1 (no)
HU (1) HUT77521A (no)
IL (1) IL116456A0 (no)
NO (1) NO972868L (no)
WO (1) WO1996019240A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5563255A (en) * 1994-05-31 1996-10-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
US5744460A (en) * 1996-03-07 1998-04-28 Novartis Corporation Combination for treatment of proliferative diseases
JP2001501975A (ja) * 1997-05-28 2001-02-13 ペーター・エー・ニールセン 亢進した細胞取り込みを有する結合ペプチド核酸
GB9718129D0 (en) 1997-08-27 1997-10-29 Isis Innovation Branched structures
US6287765B1 (en) * 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
FR2906532B1 (fr) 2006-09-28 2008-12-12 Biomerieux Sa Nouvel oligonucleotide marque
FR2933410B1 (fr) 2008-07-04 2010-08-20 Biomerieux Sa Nouvelle sonde de detection
TWI852977B (zh) 2019-01-10 2024-08-21 美商健生生物科技公司 前列腺新抗原及其用途
US12018289B2 (en) 2019-11-18 2024-06-25 Janssen Biotech, Inc. Vaccines based on mutant CALR and JAK2 and their uses
CN112898580B (zh) * 2019-12-03 2022-11-08 安序源生物科技(深圳)有限公司 测序试剂
CN112898575B (zh) * 2019-12-03 2022-10-21 深圳清华大学研究院 树杈状大分子修饰的核苷酸的制备方法
WO2022009051A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. A method for determining responsiveness to prostate cancer treatment
EP4175664A2 (en) 2020-07-06 2023-05-10 Janssen Biotech, Inc. Prostate neoantigens and their uses
WO2022009049A1 (en) 2020-07-06 2022-01-13 Janssen Biotech, Inc. Prostate neoantigens and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE89743T1 (de) * 1986-08-18 1993-06-15 Dow Chemical Co Conjugate dichter sterne.
IL107715A0 (en) * 1992-11-25 1994-02-27 Baxter Int Water soluble non-immunogenic polyamide cross-linking agents
ES2211882T3 (es) * 1993-07-14 2004-07-16 The Regents Of The University Of California Sistema de cesion de polinucleotido, automontable que comprende policationes de dendrimeros.
MX9504664A (es) * 1994-03-07 1997-05-31 Dow Chemical Co Conjugados de dendrimeros bioactivos y/o dirigidos.
IT1270994B (it) * 1994-03-18 1997-05-26 Bracco Spa Macromolecole ramificate a struttura poliossialchilica e loro usi

Also Published As

Publication number Publication date
NO972868D0 (no) 1997-06-20
IL116456A0 (en) 1996-03-31
HUT77521A (hu) 1998-05-28
CA2206915A1 (en) 1996-06-27
AU4344696A (en) 1996-07-10
WO1996019240A1 (en) 1996-06-27
JPH10510822A (ja) 1998-10-20
EP0790837A1 (en) 1997-08-27

Similar Documents

Publication Publication Date Title
NO972868L (no) Oligonukleotid-dendrimer konjugater
DK51092D0 (da) Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
ATE373671T1 (de) Aminooxy-modifizierte oligonukleotide
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
BR9813968A (pt) Moléculas de ácido nucléico que codificam proteìnas tendo atividade frutosil transferase e processos para produzir inulina de cadeia longa
EA200100365A1 (ru) Синтазы
DE69834056D1 (de) De novo oder "universaler" sequenzierungs-array
ATE420192T1 (de) Verfahren zur verringerung der antigenität des adeno-assoziierten virus strukturproteins
DE69534855D1 (de) Enzymaktive dna moleküle
DK0408295T3 (da) Fremgangsmåder til opformering af nukleinsyresekvenser
WO1998039485A3 (en) Compositions and methods for analysis of nucleic acids
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
DE69403642D1 (de) 7-deazapurin modifizierte oligonukleotide
DE69431485D1 (de) Doppelsträngige peptidenukleinsäuren
DE69524740D1 (de) Thymidin-kinase-mutanten
CY1109797T1 (el) Μορια πυρηνικου οξεος, κωδικοποιουντα ενζυμα, τα οποια διαθετουν δραστηριοτητα φρουκτοζυλικης τρανσφερασης, και η χρηση αυτων
BR9500271A (pt) Sequência de DNA vetor,plasmídeo,célula,proteína,mutante processo para o isolamento de ácidos nucléicos processo para a preparação de açúcares e empr egno
ATE87932T1 (de) Alpha-oligonukleotide.
DK0840802T3 (da) Fremgangsmåde til sekvensering gennem oligomerhybridisering
DE69815370D1 (de) Fluoreszend-konjugaten von nukleosiden und von nukleotiden, ihrer verfahren zur herstellung und ihrer verwendungen
SE9403805D0 (sv) Method of preparing oligonucleotide probes or primers, vector therefor and use thereof
ATE317123T1 (de) Reaktiver träger zur bestimmung von dna fragmenten
ATE408621T1 (de) Dna moleküle
EP0985045B1 (en) MORPHOGEN EXPRESSION MODULATORS AND CORRESPONDING IDENTIFICATION METHODS